Immunogen reported $178.01M in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Amgen AMGN:US USD 3.65B 1.23B
Astellas Pharma 4503:JP JPY 1.65T 110.47B
AstraZeneca AZN:LN USD 35.13B 798M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Eli Lilly And LLY:US USD 10.07B 1.53B
Emergent Biosolutions EBS:US USD 1.45B 63.9M
Exelixis EXEL:US USD 2.49B 100.14M
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Immunogen IMGN:US USD 178.01M 71.82M
Intrexon XON:US USD 142.53M 86.88M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Macrogenics MGNX:US USD 122.96M 19.52M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Novartis NVS:US USD 60.82B 2.1B
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Seattle Genetics SGEN:US USD 2.82B 111M